A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Conditions: Non-Small Cell Lung Carcinoma Interventions: Drug: Lorlatinib Sponsors: Pfizer Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Learning | Lung Cancer | Non-Small Cell Lung Cancer | Pfizer | Research | Study | Universities & Medical Training